I appreciate you raking the time too :) And that’s a good question actually.

I think it’s possible if antivirals that inhibit Covid-19 virus is properly designed. Then maybe adding a carrier that could help the antiviral travel across the blood-brain-barrier (BBB) would solve the problem. If the antiviral can cross the BBB on its own, then it’s even better.

Another possibility is that the immune system clears it on its own, which should be the case in the majority of infected people with mild or no symptoms.